15 completed. 6 Phase 4, 4 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 6 |
| Phase 3 | 4 | Completed 4 |
| Not applicable | 1 | Completed 1 |
Follow Ganfort: new trials by email Literature Review of Ganfort trials Research Report on Ganfort
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients. Bimatoprost Timolol (T4030), Bimatoprost Timolol (Ganfort) - Ocular Hypertension Glaucoma | Phase 3 | Completed | Laboratoires Thea | 554 | 2021-03-26 | 2023-07-21 |
| Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension Netarsudil/Latanoprost 0.02%/0.005%, GANFORT® - Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Aerie Pharmaceuticals | 436 | 2017-09-05 | 2022-01-31 |
| Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension bimatoprost 0.03% plus timolol 0.5% - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Completed | Allergan | 750 | 2015-11-10 | 2018-07-05 |
| Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol Maleate) 5 Mg/mL Eye Drops, Brinzolamide/Timolol 10 MG/1 ML-5 MG/1 ML Ophthalmic Suspension - Glaucoma, Open-Angle | Phase 4 | Completed | Afyon Kocatepe University Hospital | 96 | 2014-01-01 | 2019-05-29 |
| A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Bimatoprost - Glaucoma, Open-Angle, Ocular Hypertension | Completed | Allergan | 2580 | 2012-05-01 | 2014-06-13 | |
| Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG travoprost and timolol maleate fixed combination, latanoprost and maleate timolol fixed combination, bimatoprost and timolol maleate fixed combination - Uveitis, Anterior, Cystoid Macular Edema | Phase 4 | Completed | University of Campinas, Brazil | 69 | 2011-10-01 | 2013-11-07 |
| Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Ganforti, Krytantek - Glaucoma Primary Open Angle | Completed | Allergan S.A. DE C.V.. | 90 | 2011-02-01 | 2012-11-30 | |
| Bimatoprost/Timolol Versus Travoprost/Timolol Ganfort, Duotrav - Glaucoma | Not applicable | Completed | Kasr El Aini Hospital | 80 | 2011-01-01 | 2012-03-02 |
| Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension bimatoprost /timolol formulation A fixed combination ophthalmic solution, bimatoprost/timolol fixed combination ophthalmic solution - Glaucoma, Ocular Hypertension | Phase 3 | Completed | Allergan | 561 | 2010-10-01 | 2013-03-29 |
| A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Ganfort, Duotrav - Ocular Hypertension, Primary Open Angle Glaucoma | Phase 3 | Completed | Ministry of Health, Malaysia | 42 | 2010-08-01 | 2011-07-08 |
| Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution, latanoprost 0.005% ophthalmic solution - Glaucoma, Open-Angle | Phase 4 | Completed | Allergan | 81 | 2010-06-01 | 2019-04-18 |
| 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice Bimatoprost/Timolol, 24-hour intraocular pressure monitoring, Latanoprost, 24-hour intraocular pressure monitoring - Glaucoma | Phase 4 | Completed | Aristotle University Of Thessaloniki | 37 | 2010-04-01 | 2014-05-12 |
| Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom XALACOM, Duotrav, Ganfort - Glaucoma, Ocular Hypertension | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2015 | 2010-02-01 | 2021-02-02 | |
| Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea bimatoprost/timolol - Glaucoma, Open-Angle, Ocular Hypertension | Completed | Allergan | 756 | 2009-08-01 | 2015-09-28 | |
| Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination Bimatoprost and Bimatoprost/Timolol fixed combination. - Glaucoma, Ocular Hypertension | Phase 4 | Completed | Larissa University Hospital | 30 | 2009-07-01 | 2010-11-30 |
Glaucoma, Open-Angle (9) · Ocular Hypertension (9) · Glaucoma (5) · Macular Edema (1) · Uveitis, Anterior (1)
Allergan (5) · Aerie Pharmaceuticals (1) · Afyon Kocatepe University Hospital (1) · Allergan S.A. DE C.V.. (1) · Aristotle University Of Thessaloniki (1) · Kasr El Aini Hospital (1) · Laboratoires Thea (1) · Larissa University Hospital (1) · Ministry of Health, Malaysia (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · University of Campinas, Brazil (1)
Germany (3) · Spain (3) · Czechia (2) · Greece (2) · Hungary (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · China (1) · Egypt (1) · France (1) · Israel (1)
Alana M Santana, MD (1) · Anastasios G Konstas, MD, PhD (1) · Anne McLaughlin (1) · Jose A Paczka, MD (1) · Karen Ortiz (1) · Michelle Senchyna (1) · Tamer A Macky, MD FRCS (1)
PMID 24667994, PMID 25527295, PMID 36370233
2009 (1)